President, Global Plasma
Thomas McCurdy joined Haemonetics in 2010 as Vice President, North American Patient Sales.
championed the development of the Company's innovative Comprehensive Blood Management Solutions ("CBMS") initiative, led the growth and development of the TEG business in North America, and drove the integration of software and device "connectivity" as a critical platform for customer and market engagement.
He was promoted to President, Global Plasma in 2015.
Prior to joining Haemonetics, Mr. McCurdy gained 25 years of worldwide sales experience in roles of increasing responsibility at Navilyst Medical, Boston Scientific and Procter & Gamble.